Latest News & Features
Americas
Drug company Watson Laboratories (Actavis) has notified rival Ranbaxy Laboratories that it has applied to sell a generic version of anti-acne product Absorica in the US. 24 September 2013
Americas
Medical device makers Boston Scientific and OrbusNeich announced on September 17 that they have settled all stent-related patent litigations. 18 September 2013
Americas
Eli Lilly has filed a NOA against the Canadian government, alleging recent decisions that invalidated patents covering its Zyprexa and Strattera drugs were in breach of NAFTA. 17 September 2013
Asia
The Indian government has awarded more than two thirds of its recent pharmaceutical patents to foreign drug makers, according to data released by the Indian Patent Office. 16 September 2013
Europe
UK biopharmaceuticals company PolyTherics has completed a takeover of Antitope, a provider of antibody engineering and immunogenicity screening services. 12 September 2013
Asia
The Health Ministry in India has recommended that a compulsory licence is issued for the manufacture of Bristol-Myers Squibb’s anti-cancer drug Sprycel (dasatinib), potentially opening the door to the sale of cheaper imitations. 12 September 2013
Americas
The annual International Association for the Protection of Intellectual Property conference in Helsinki has been assessing the potential problems for pharmaceutical companies trying to brand their medicinal products. 7 September 2013
Asia-Pacific
Law firm Rouse has teamed up with two organisations to open the BioEconomy Academy, an initiative aimed at boosting IP use and awareness in Thailand. 4 September 2013
Asia
There has been much debate about whether there is a global deterioration of IP, and many commentators
would suggest that India is leading the charge. Andrew Jenner and Ernest Kawka reflect on the experiences of innovative biopharmaceutical companies in India. 31 August 2013
Big Pharma
A decision from an opposition division of the European Patent Office may have “far-reaching consequences” for US patent holders, Solveig Moré tells LSIPR. 31 August 2013